morpholinoanthracycline mx2 has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohnishi, K; Ohno, R | 1 |
| Kuraishi, Y; Ogawa, M; Okabe, K; Sampi, K; Takemoto, Y; Tamura, K | 1 |
1 review(s) available for morpholinoanthracycline mx2 and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
[New antitumor drugs for malignant lymphoma: a review].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carubicin; Clinical Trials, Phase II as Topic; Female; Humans; Irinotecan; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Piperazines | 1994 |
1 trial(s) available for morpholinoanthracycline mx2 and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
[Phase II study of KRN8602 (MX2) for malignant lymphoma].
Topics: Anorexia; Antibiotics, Antineoplastic; Carubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Nausea; Thrombocytopenia; Vomiting | 1998 |